MedPath

AXBERI HP

AXBERI HP

Approved
DIN Number

02540037

Drug Class

Human

Market Date

Oct 15, 2024

Company
HC

baxter corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02540037
AIG Number0131860002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AB05 ENOXAPARIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous ,  Subcutaneous
AHFS Classification20:12.04.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

ENOXAPARIN SODIUMActive
Strength: 150 MG / ML
Monograph: ENOXAPARIN SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.